AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
-12.54%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$1.8B
AUM Growth
+$1.8B
(-24%)
Cap. Flow
-$127M
Cap. Flow
% of AUM
-7.06%
Top 10 Holdings %
Top 10 Hldgs %
51.01%
Holding
142
New
4
Increased
8
Reduced
8
Closed
7
Top Buys
| 1 |
Scholar Rock
SRRK
|
$34.6M |
| 2 |
Fate Therapeutics
FATE
|
$14.9M |
| 3 |
Cytokinetics
CYTK
|
$10.8M |
| 4 |
Wave Life Sciences
WVE
|
$6.5M |
| 5 |
CINC
CinCor Pharma, Inc. Common Stock
CINC
|
$2.58M |
Top Sells
| 1 |
argenx
ARGX
|
$71M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$22.1M |
| 3 |
Protagonist Therapeutics
PTGX
|
$18.9M |
| 4 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$16.8M |
| 5 |
BLU
BELLUS Health Inc.
BLU
|
$13.9M |
Sector Composition
| 1 | Healthcare | 93.1% |
| 2 | Consumer Discretionary | 5.5% |
| 3 | Financials | 0.65% |
| 4 | Consumer Staples | 0.29% |
| 5 | Industrials | 0.16% |
